Skip to main content
Log in

Testosterone Prescribing in Texas, 2018–2021

  • Concise Research Report
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Baillargeon J, Kuo YF, Westra JR, Urban RJ, Goodwin JS. Testosterone Prescribing in the United States, 2002-2016. JAMA. 2018;320(2):200-202. https://doi.org/10.1001/jama.2018.7999. PMID: 29998328; PMCID: PMC6396809.

    Article  PubMed  PubMed Central  Google Scholar 

  2. de Dios C, Fernandes BS, Whalen K, Bandewar S, Suchting R, Weaver MF, Selvaraj S. Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States. Drug Alcohol Depend. 2021;229(Pt A):109176. https://doi.org/10.1016/j.drugalcdep.2021.109176. Epub 2021 Nov 17. PMID: 34808468; PMCID: PMC8595244.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM Jr, Wang Q, Wolski K, Davey D, Kalahasti V, Khan N, Miller MG, Snabes MC, Chan A, Dubcenco E, Li X, Yi T, Huang B, Pencina KM, Travison TG, Nissen SE; TRAVERSE Study Investigators. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023. https://doi.org/10.1056/NEJMoa2215025. Epub ahead of print.

  4. Walker RF, Zakai NA, MacLehose RF, Cowan LT, Adam TJ, Alonso A, Lutsey PL. Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism. JAMA Intern Med. 2020;180(2):190-197. https://doi.org/10.1001/jamainternmed.2019.5135. PMID: 31710339; PMCID: PMC6865248.

    Article  CAS  PubMed  Google Scholar 

  5. Morden NE, Woloshin S, Brooks CG, Schwartz LM. Trends in Testosterone Prescribing for Age-related Hypogonadism in Men With and Without Heart Disease. JAMA Intern Med. 2019 ;179(3):446-448. https://doi.org/10.1001/jamainternmed.2018.6505. PMID: 30592484; PMCID: PMC6440228.

    Article  PubMed  Google Scholar 

  6. Dubin JM, Jesse E, Fantus RJ, Bennett NE, Brannigan RE, Thirumavalavan N, Halpern JA. Guideline-Discordant Care Among Direct-to-Consumer Testosterone Therapy Platforms. JAMA Intern Med. 2022;182(12):1321-1323. https://doi.org/10.1001/jamainternmed.2022.4928. PMID: 36469030; PMCID: PMC9855289.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Scott Selinger MD, FACP.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Selinger, S., Ancha, N. & Frei, C.R. Testosterone Prescribing in Texas, 2018–2021. J GEN INTERN MED 38, 3436–3438 (2023). https://doi.org/10.1007/s11606-023-08316-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-023-08316-y

Navigation